Drugs / hydroxyethyl starch 70/0.5
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01010022 Comparator | Nov 2009 → Jul 2010 | hemorrhagic disease | Fresenius Kabi Japan | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | hydroxyethyl starch 70/0.5 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01010022 ↗ |
| Known as | Salinhes | “Up to 1000mL 6% hydroxyethyl starch 70/0.5 (Salinhes®) solution i.v., intra-operatively (from start of surgery until end of surgery)” NCT01010022 ↗ |
| Route | Intravenous | “Up to 1000mL 6% hydroxyethyl starch 70/0.5 (Salinhes®) solution i.v., intra-operatively (from start of surgery until end of surgery)” NCT01010022 ↗ |